Top

Published in:

01-05-2016 | Review

Comorbid depression in obstructive sleep apnea: an under-recognized association

Authors: Ahmed S. BaHammam, Tetyana Kendzerska, Ravi Gupta, Chellamuthu Ramasubramanian, David N. Neubauer, Meera Narasimhan, Seithikurippu R. Pandi-Perumal, Adam Moscovitch

Published in: Sleep and Breathing | Issue 2/2016

Abstract

Background

Obstructive sleep apnea (OSA) and depression may coexist in the same patient. This article aims to review the link between OSA and comorbid depression and critically evaluate the results of studies that assessed the correlation between OSA and depression, the impact of OSA treatment on comorbid depression, and the impact of comorbid depression on continuous positive airway pressure (CPAP) adherence.

Methods

An integrative review was conducted on English language studies and reports that assessed the relationship between OSA and depression. Studies were identified by searching PubMed, Web of Science and Google Scholar databases, and reference lists of included studies.

Results

Generally, cross-sectional studies show a higher prevalence of depression among OSA patients with both community and sleep disorder clinic samples. Nevertheless, the relationship between OSA and depression is complicated by the fact that the disorders have overlapping symptoms. Longitudinal studies demonstrate an increased risk of developing depression among people with OSA, as well as an association between OSA severity and the likelihood of developing depression. On the other hand, studies assessing the impact of CPAP therapy on depression among OSA patients report conflicting results. Therefore, it is essential to consider how the disorders affect one another and to understand the clinical consequences of treating each disorder in isolation.

Conclusion

Depression is prevalent among patients with OSA both in the community and in sleep disorder clinics. Clinicians in general should be aware of this significant association and should aim to treat both disorders.

American Psychiatric Association (DSM-5) (2013) Diagnostic and statistical manual of mental disorders, 5th edn. Washington, DC

Ye L, Pien GW, Ratcliffe SJ, Bjornsdottir E, Arnardottir ES, Pack AI, Benediktsdottir B, Gislason T (2014) The different clinical faces of obstructive sleep apnoea: a cluster analysis. Eur Respir J. doi:10.1183/09031936.00032314

Gagnon K, Baril AA, Gagnon JF, Fortin M, Decary A, Lafond C, Desautels A, Montplaisir J, Gosselin N (2014) Cognitive impairment in obstructive sleep apnea. Pathol Biol (Paris) 62(5):233–240. doi:10.1016/j.patbio.2014.05.015 CrossRef

Harris M, Glozier N, Ratnavadivel R, Grunstein RR (2009) Obstructive sleep apnea and depression. Sleep Med Rev 13(6):437–444. doi:10.1016/j.smrv.2009.04.001 PubMedCrossRef

Aloia MS, Arnedt JT, Smith L, Skrekas J, Stanchina M, Millman RP (2005) Examining the construct of depression in obstructive sleep apnea syndrome. Sleep Med 6(2):115–121. doi:10.1016/j.sleep.2004.09.003 PubMedCrossRef

Farney RJ, Lugo A, Jensen RL, Walker JM, Cloward TV (2004) Simultaneous use of antidepressant and antihypertensive medications increases likelihood of diagnosis of obstructive sleep apnea syndrome. Chest 125(4):1279–1285PubMedCrossRef

Peppard PE, Szklo-Coxe M, Hla KM, Young T (2006) Longitudinal association of sleep-related breathing disorder and depression. Arch Intern Med 166(16):1709–1715. doi:10.1001/archinte.166.16.1709 PubMedCrossRef

Chen HL, Lu CH, Lin HC, Chen PC, Chou KH, Lin WM, Tsai NW, Su YJ, Friedman M, Lin CP, Lin WC (2015) White matter damage and systemic inflammation in obstructive sleep apnea. Sleep 38(3):361–370

Berk M, Williams LJ, Jacka FN, O’Neil A, Pasco JA, Moylan S, Allen NB, Stuart AL, Hayley AC, Byrne ML, Maes M (2013) So depression is an inflammatory disease, but where does the inflammation come from? BMC Med 11:200. doi:10.1186/1741-7015-11-200 PubMedPubMedCentral

10.

Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571PubMedCrossRef

11.

Weissman MM, Sholomskas D, Pottenger M, Prusoff BA, Locke BZ (1977) Assessing depressive symptoms in five psychiatric populations: a validation study. Am J Epidemiol 106(3):203–214PubMed

12.

Gough HG (1946) Diagnostic patterns on the Minnesota Multiphasic Personality Inventory. J Clin Psychol 2:23–37PubMedCrossRef

13.

Chandarana PC, Eals M, Steingart AB, Bellamy N, Allen S (1987) The detection of psychiatric morbidity and associated factors in patients with rheumatoid arthritis. Can J Psychiatry 32(5):356–361PubMed

14.

Kroenke K, Spitzer RL, Williams JB (2001) The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16(9):606–613PubMedPubMedCentralCrossRef

15.

Derogatis LR, Lipman RS, Covi L (1973) SCL-90: an outpatient psychiatric rating scale—preliminary report. Psychopharmacol Bull 9(1):13–28PubMed

16.

Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59(Suppl 20):22–33, quiz 34–57 PubMed

17.

Zung WW (1965) A Self-Rating Depression Scale. Arch Gen Psychiatry 12:63–70PubMedCrossRef

18.

Ohayon MM (2003) The effects of breathing-related sleep disorders on mood disturbances in the general population. J Clin Psychiatry 64(10):1195–1200, quiz, 1274–1196 PubMedCrossRef

19.

Sharafkhaneh A, Giray N, Richardson P, Young T, Hirshkowitz M (2005) Association of psychiatric disorders and sleep apnea in a large cohort. Sleep 28(11):1405–1411PubMed

20.

Wheaton AG, Perry GS, Chapman DP, Croft JB (2012) Sleep disordered breathing and depression among U.S. adults: National Health and Nutrition Examination Survey, 2005–2008. Sleep 35(4):461–467. doi:10.5665/sleep.1724 PubMedPubMedCentral

21.

Sivertsen B, Overland S, Glozier N, Bjorvatn B, Maeland JG, Mykletun A (2008) The effect of OSAS on sick leave and work disability. Eur Respir J 32(6):1497–1503. doi:10.1183/09031936.00044908 PubMedCrossRef

22.

Ejaz SM, Khawaja IS, Bhatia S, Hurwitz TD (2011) Obstructive sleep apnea and depression: a review. Innov Clin Neurosci 8(8):17–25PubMedPubMedCentral

23.

Schwartz DJ, Kohler WC, Karatinos G (2005) Symptoms of depression in individuals with obstructive sleep apnea may be amenable to treatment with continuous positive airway pressure. Chest 128(3):1304–1309. doi:10.1378/chest.128.3.1304 PubMedCrossRef

24.

Yamamoto H, Akashiba T, Kosaka N, Ito D, Horie T (2000) Long-term effects nasal continuous positive airway pressure on daytime sleepiness, mood and traffic accidents in patients with obstructive sleep apnoea. Respir Med 94(1):87–90. doi:10.1053/rmed.1999.0698 PubMedCrossRef

25.

Vandeputte M, de Weerd A (2003) Sleep disorders and depressive feelings: a global survey with the Beck depression scale. Sleep Med 4(4):343–345PubMedCrossRef

26.

Wahner-Roedler DL, Olson EJ, Narayanan S, Sood R, Hanson AC, Loehrer LL, Sood A (2007) Gender-specific differences in a patient population with obstructive sleep apnea-hypopnea syndrome. Gend Med 4(4):329–338PubMedCrossRef

27.

Alotair H, Bahammam A (2008) Gender differences in Saudi patients with obstructive sleep apnea. Sleep Breath 12(4):323–329. doi:10.1007/s11325-008-0184-8 PubMedCrossRef

28.

McCall WV, Harding D, O’Donovan C (2006) Correlates of depressive symptoms in patients with obstructive sleep apnea. J Clin Sleep Med 2(4):424–426PubMed

29.

Asghari A, Mohammadi F, Kamrava SK, Tavakoli S, Farhadi M (2012) Severity of depression and anxiety in obstructive sleep apnea syndrome. Eur Arch Otorhinolaryngol 269(12):2549–2553. doi:10.1007/s00405-012-1942-6 PubMedCrossRef

30.

Rey de Castro J, Rosales-Mayor E (2013) Depressive symptoms in patients with obstructive sleep apnea/hypopnea syndrome. Sleep Breath 17(2):615–620. doi:10.1007/s11325-012-0731-1 PubMedCrossRef

31.

Douglas N, Young A, Roebuck T, Ho S, Miller BR, Kee K, Dabscheck EJ, Naughton MT (2013) Prevalence of depression in patients referred with snoring and obstructive sleep apnoea. Intern Med J 43(6):630–634. doi:10.1111/imj.12108 PubMedCrossRef

32.

Phillips BA, Berry DT, Lipke-Molby TC (1996) Sleep-disordered breathing in healthy, aged persons. Fifth and final year follow-up. Chest 110(3):654–658PubMedCrossRef

33.

Pillar G, Lavie P (1998) Psychiatric symptoms in sleep apnea syndrome: effects of gender and respiratory disturbance index. Chest 114(3):697–703PubMedCrossRef

34.

Bajpai S, Im KB, Dyken ME, Sodhi SK, Fiedorowicz JG (2014) Obstructive sleep apnea and risk for late-life depression. Ann Clin Psychiatry 26(2):E1–E8

35.

Yilmaz E, Sedky K, Bennett DS (2013) The relationship between depressive symptoms and obstructive sleep apnea in pediatric populations: a meta-analysis. J Clin Sleep Med 9(11):1213–1220. doi:10.5664/jcsm.3178 PubMedPubMedCentral

36.

Kripke DF, Ancoli-Israel S, Klauber MR, Wingard DL, Mason WJ, Mullaney DJ (1997) Prevalence of sleep-disordered breathing in ages 40–64 years: a population-based survey. Sleep 20(1):65–76PubMedPubMedCentral

37.

Ishman SL, Cavey RM, Mettel TL, Gourin CG (2010) Depression, sleepiness, and disease severity in patients with obstructive sleep apnea. Laryngoscope 120(11):2331–2335. doi:10.1002/lary.21111 PubMedCrossRef

38.

Macey PM, Woo MA, Kumar R, Cross RL, Harper RM (2010) Relationship between obstructive sleep apnea severity and sleep, depression and anxiety symptoms in newly-diagnosed patients. PLoS One 5(4), e10211. doi:10.1371/journal.pone.0010211 PubMedPubMedCentralCrossRef

39.

Enright PL, Newman AB, Wahl PW, Manolio TA, Haponik EF, Boyle PJ (1996) Prevalence and correlates of snoring and observed apneas in 5,201 older adults. Sleep 19(7):531–538PubMed

40.

Smith R, Ronald J, Delaive K, Walld R, Manfreda J, Kryger MH (2002) What are obstructive sleep apnea patients being treated for prior to this diagnosis? Chest 121(1):164–172PubMedCrossRef

41.

Sforza E, de Saint HZ, Pelissolo A, Rochat T, Ibanez V (2002) Personality, anxiety and mood traits in patients with sleep-related breathing disorders: effect of reduced daytime alertness. Sleep Med 3(2):139–145PubMedCrossRef

42.

Lee W, Lee SA, Chung YS, Kim WS (2015) The relation between apnea and depressive symptoms in men with severe obstructive sleep apnea: mediational effects of sleep quality. Lung 193(2):261–267. doi:10.1007/s00408-015-9687-9 PubMedCrossRef

43.

Chen YH, Keller JK, Kang JH, Hsieh HJ, Lin HC (2013) Obstructive sleep apnea and the subsequent risk of depressive disorder: a population-based follow-up study. J Clin Sleep Med 9(5):417–423. doi:10.5664/jcsm.2652 PubMedPubMedCentral

44.

Daabis R, Gharraf H (2012) Predictors of anxiety and depression in patients with obstructive sleep apnea. Egypt J Chest Dis Tuberc 61:171–177CrossRef

45.

Rezaeitalab F, Moharrari F, Saberi S, Asadpour H, Rezaeetalab F (2014) The correlation of anxiety and depression with obstructive sleep apnea syndrome. J Res Med Sci 19(3):205–210PubMedPubMedCentral

46.

McDaid C, Griffin S, Weatherly H, Duree K, van der Burgt M, van Hout S, Akers J, Davies RJ, Sculpher M, Westwood M (2009) Continuous positive airway pressure devices for the treatment of obstructive sleep apnoea-hypopnoea syndrome: a systematic review and economic analysis. Health Technol Assess 13 (4):iii-iv, xi-xiv, 1–119, 143–274. doi:10.3310/hta13040

47.

Bazzano LA, Khan Z, Reynolds K, He J (2007) Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension 50(2):417–423. doi:10.1161/HYPERTENSIONAHA.106.085175 PubMedCrossRef

48.

Kawahara S, Akashiba T, Akahoshi T, Horie T (2005) Nasal CPAP improves the quality of life and lessens the depressive symptoms in patients with obstructive sleep apnea syndrome. Intern Med 44(5):422–427PubMedCrossRef

49.

Diamanti C, Manali E, Ginieri-Coccossis M, Vougas K, Cholidou K, Markozannes E, Bakakos P, Liappas I, Alchanatis M (2013) Depression, physical activity, energy consumption, and quality of life in OSA patients before and after CPAP treatment. Sleep Breath 17(4):1159–1168. doi:10.1007/s11325-013-0815-6 PubMedCrossRef

50.

Giles TL, Lasserson TJ, Smith BH, White J, Wright J, Cates CJ (2006) Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev 3, CD001106. doi:10.1002/14651858.CD001106.pub3 PubMed

51.

Henke KG, Grady JJ, Kuna ST (2001) Effect of nasal continuous positive airway pressure on neuropsychological function in sleep apnea-hypopnea syndrome. A randomized, placebo-controlled trial. Am J Respir Crit Care Med 163(4):911–917. doi:10.1164/ajrccm.163.4.9910025 PubMedCrossRef

52.

Haensel A, Norman D, Natarajan L, Bardwell WA, Ancoli-Israel S, Dimsdale JE (2007) Effect of a 2 week CPAP treatment on mood states in patients with obstructive sleep apnea: a double-blind trial. Sleep Breath 11(4):239–244. doi:10.1007/s11325-007-0115-0 PubMedCrossRef

53.

Bardwell WA, Norman D, Ancoli-Israel S, Loredo JS, Lowery A, Lim W, Dimsdale JE (2007) Effects of 2-week nocturnal oxygen supplementation and continuous positive airway pressure treatment on psychological symptoms in patients with obstructive sleep apnea: a randomized placebo-controlled study. Behav Sleep Med 5(1):21–38. doi:10.1080/15402000709336724 PubMedCrossRef

54.

Povitz M, Bolo CE, Heitman SJ, Tsai WH, Wang J, James MT (2014) Effect of treatment of obstructive sleep apnea on depressive symptoms: systematic review and meta-analysis. PLoS Med 11(11), e1001762. doi:10.1371/journal.pmed.1001762 PubMedPubMedCentralCrossRef

55.

Habukawa M, Uchimura N, Kakuma T, Yamamoto K, Ogi K, Hiejima H, Tomimatsu K, Matsuyama S (2010) Effect of CPAP treatment on residual depressive symptoms in patients with major depression and coexisting sleep apnea: contribution of daytime sleepiness to residual depressive symptoms. Sleep Med 11(6):552–557. doi:10.1016/j.sleep.2010.02.007 PubMedCrossRef

56.

Gagnadoux F, Le Vaillant M, Goupil F, Pigeanne T, Chollet S, Masson P, Bizieux-Thaminy A, Humeau MP, Meslier N (2014) Depressive symptoms before and after long-term CPAP therapy in patients with sleep apnea. Chest 145(5):1025–1031. doi:10.1378/chest.13-2373 PubMedCrossRef

57.

Kjelsberg FN, Ruud EA, Stavem K (2005) Predictors of symptoms of anxiety and depression in obstructive sleep apnea. Sleep Med 6(4):341–346. doi:10.1016/j.sleep.2005.02.004 PubMedCrossRef

58.

Grenard JL, Munjas BA, Adams JL, Suttorp M, Maglione M, McGlynn EA, Gellad WF (2011) Depression and medication adherence in the treatment of chronic diseases in the United States: a meta-analysis. J Gen Intern Med 26(10):1175–1182. doi:10.1007/s11606-011-1704-y PubMedPubMedCentralCrossRef

59.

Poulet C, Veale D, Arnol N, Levy P, Pepin JL, Tyrrell J (2009) Psychological variables as predictors of adherence to treatment by continuous positive airway pressure. Sleep Med 10(9):993–999. doi:10.1016/j.sleep.2009.01.007 PubMedCrossRef

60.

Lewis KE, Seale L, Bartle IE, Watkins AJ, Ebden P (2004) Early predictors of CPAP use for the treatment of obstructive sleep apnea. Sleep 27(1):134–138PubMed

61.

Stepnowsky CJ Jr, Bardwell WA, Moore PJ, Ancoli-Israel S, Dimsdale JE (2002) Psychologic correlates of compliance with continuous positive airway pressure. Sleep 25(7):758–762PubMed

62.

Law M, Naughton M, Ho S, Roebuck T, Dabscheck E (2014) Depression may reduce adherence during CPAP titration trial. J Clin Sleep Med 10(2):163–169. doi:10.5664/jcsm.3444 PubMedPubMedCentral

63.

Wallace DM, Vargas SS, Schwartz SJ, Aloia MS, Shafazand S (2013) Determinants of continuous positive airway pressure adherence in a sleep clinic cohort of South Florida Hispanic veterans. Sleep Breath 17(1):351–363. doi:10.1007/s11325-012-0702-6 PubMedCrossRef

64.

Wallace DM, Wohlgemuth WK (2014) Does race-ethnicity moderate the relationship between CPAP adherence and functional outcomes of sleep in US veterans with obstructive sleep apnea syndrome? J Clin Sleep Med 10(10):1083–1091. doi:10.5664/jcsm.4106 PubMedPubMedCentral

65.

Means MK, Ulmer CS, Edinger JD (2010) Ethnic differences in continuous positive airway pressure (CPAP) adherence in veterans with and without psychiatric disorders. Behav Sleep Med 8(4):260–273. doi:10.1080/15402002.2010.509255 PubMedCrossRef

66.

Kasasbeh E, Chi DS, Krishnaswamy G (2006) Inflammatory aspects of sleep apnea and their cardiovascular consequences. South Med J 99(1):58–67. doi:10.1097/01.smj.0000197705.99639.50, quiz 68–59, 81 PubMedCrossRef

67.

Irwin MR, Miller AH (2007) Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav Immun 21(4):374–383. doi:10.1016/j.bbi.2007.01.010 PubMedCrossRef

68.

Katon W, Lin EH, Kroenke K (2007) The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. Gen Hosp Psychiatry 29(2):147–155. doi:10.1016/j.genhosppsych.2006.11.005 PubMedCrossRef

Title: Comorbid depression in obstructive sleep apnea: an under-recognized association
Authors: Ahmed S. BaHammam
Tetyana Kendzerska
Ravi Gupta
Chellamuthu Ramasubramanian
David N. Neubauer
Meera Narasimhan
Seithikurippu R. Pandi-Perumal
Adam Moscovitch
Publication date: 01-05-2016
Publisher: Springer Berlin Heidelberg
Published in: Sleep and Breathing / Issue 2/2016
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI: https://doi.org/10.1007/s11325-015-1223-x

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 2/2016

Poor sleep quality associated with obesity in men

Self-reported obstructive sleep apnea, simple snoring, and various markers of sleep-disordered breathing as predictors of cardiovascular risk

The Determining Risk of Vascular Events by Apnea Monitoring (DREAM) study: design, rationale, and methods

Oral appliance in sleep apnea treatment: respiratory and clinical effects and long-term adherence

A telehealth program for CPAP adherence reduces labor and yields similar adherence and efficacy when compared to standard of care

Age and severity matched comparison of gender differences in the prevalence of periodic limb movements during sleep in patients with obstructive sleep apnea

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage